Navigation Links
Trubion Pharmaceuticals to Present at the Lazard Capital Markets Healthcare Investor Conference
Date:11/21/2007

SEATTLE, Nov. 21 /PRNewswire-FirstCall/ -- Trubion Pharmaceuticals Inc. (Nasdaq: TRBN) today announced that Dr. Peter Thompson, president, chief executive officer and chairman of Trubion, is scheduled to present a corporate update at the upcoming Lazard Capital Markets Healthcare Investor Conference to be held at The New York Palace Hotel. Dr. Thompson is scheduled to present Nov. 27, 2007, at 2:30 p.m. Interested parties may access the live audio webcast of the presentation by visiting the Wall Street Webcasting link at http://www.wsw.com/webcast/lz4/trbn.

About Trubion

Trubion is a biopharmaceutical company creating a pipeline of product candidates to treat autoimmune disease and cancer. The company's product candidates are novel proteins known as single-chain polypeptides and are designed using its SMIP(TM) custom drug assembly technology. In less than 24 months, the company designed, developed and submitted to the FDA an Investigational New Drug (IND) application for its lead product candidate, TRU-015, which has completed a Phase IIb clinical trial for the treatment of rheumatoid arthritis. In December 2005, the company entered into a collaboration agreement with Wyeth for the development and worldwide commercialization of certain therapeutics, including TRU-015. In addition, Trubion's TRU-016 program targets CD37, an antigen present on B cells, for the treatment of non-Hodgkin's lymphoma and chronic lymphocytic leukemia. The company filed an IND for TRU-016 in the fourth quarter of 2007. Trubion currently retains all development and commercialization rights for the TRU-016 program. For additional information, visit

SOURCE Trubion Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Trubion Pharmaceuticals to Present at Upcoming Investor Conferences
2. Trubion Pharmaceuticals Announces Upcoming Presentations at American College of Rheumatology Annual Scientific Meeting
3. Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2007 Financial Results
4. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
5. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
8. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
9. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
10. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
11. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... June 29, 2015 ... the addition of the "Biotechnology for the ... Biotechnology for the Non-Biotechnologist, ideal for non-Scientists and ... techniques and potential of biotechnology. Ideal ... basic theory, principles, techniques, and potential of biotechnology ...
(Date:7/5/2015)... ... ... For many years, metal-on-quartz filters were the industry standard for the calibration ... Cary 4000-7000, a Perkin Elmer 800-1100 or a Shimadzu 3600-3700, these filters would work ... their SRM-2031 series going back for many years. Unfortunately, these standards remained unusable for ...
(Date:7/3/2015)... ... ... The global failure analysis market is expected to reach $7,147.0 million by 2020, ... to grow at the highest CAGR of 8.46%; its growth is expected to be ... academic institutions for root cause analysis of failure. The market based on the geographic ...
(Date:7/3/2015)... , July 3, 2015 ... 22. september 2015 på  http://www.openinnovationinscience.at om ... der finder sted i Wien ... undersøgelse af internationale forskere og videnskabsmænd foretaget ... to største udfordringer for sundhedsvidenskaben manglen på ...
Breaking Biology Technology:FireflySci Simplifies the Calibration of UV Spectrophotometers with FUV Photometric Accuracy Standards 2FireflySci Simplifies the Calibration of UV Spectrophotometers with FUV Photometric Accuracy Standards 3Failure Analysis Market to Grow at 7.52% CAGR to 2020 2Failure Analysis Market to Grow at 7.52% CAGR to 2020 3Failure Analysis Market to Grow at 7.52% CAGR to 2020 4Failure Analysis Market to Grow at 7.52% CAGR to 2020 5Lancering af verdens første åbne innovationsprogram til uddannelse af forskere 2Lancering af verdens første åbne innovationsprogram til uddannelse af forskere 3
... to announce,that their new, unique immunoassay Rat/Mouse PINP- the ... I collagen levels in rodent,specimens*, is now available., ... to allow the,specific assessment of type I collagen levels ... the assessment of new osteoporosis drug candidates,in pre-clinical studies ...
... Cell Therapeutics, Inc.,(CTI) (Nasdaq and MTAX: CTIC) ... e la Borsa ("CONSOB") granted authorization to,publish the ... by Article 8 and Article 56 of the ... common stock representing more than 10% of,the shares ...
... Dec. 2008, ATLANTA, Jan. 11 Cryolife, Inc., ... tissue has once again severely,maimed an elective knee surgery ... Shockingly the same deadly,organism that devastated Mr. Hohenbery took ... The Lykins, death, another of the Keenan Law ...
Cached Biology Technology:A New, Unique and Unrivalled Rat/Mouse PINP Assay for Pharmaceutical, Clinical and Academic Research Organizations. 2Cell Therapeutics, Inc. Announces Authorization to Publish Italian Listing Prospectus 2Cell Therapeutics, Inc. Announces Authorization to Publish Italian Listing Prospectus 3Cryolife Once Again Severely Maims an Innocent Knee Surgery Patient 2
(Date:6/10/2015)... , June 10, 2015 ... "3D Sensor Market by Technology (Ultrasound, TOF, Structured ... (consumer Electronics, Entertainment, Automotive) and by Geography - ... by MarketsandMarkets, the market is expected to reach ... of 25.51% between 2015 and 2020. ...
(Date:6/9/2015)... , June 09, 2015 Research and ... of the "Gesture Recognition & Touchless Sensing ... Electronics, Automotive, & Others), Product (Biometric & Sanitary ... 2020" report to their offering. ... is expected to reach $ 23.55 Billion by ...
(Date:6/8/2015)... WASHINGTON , June 8, 2015  The ... announced today their selection of Troy Potter ... Chairman, effective immediately. SIBA is a non-profit association ... promote responsible policy, education and implementation of solutions ... public platforms. ...
Breaking Biology News(10 mins):3D Sensor Market Worth $3,319.71 Million by 2020 23D Sensor Market Worth $3,319.71 Million by 2020 33D Sensor Market Worth $3,319.71 Million by 2020 4Global Gesture Recognition & Touchless Sensing (Technology, Application & Products) Market 2015-2020 2Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 2Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 3Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 4Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 5
... Washington D.C. Researchers at the U.S. Department ... today a major breakthrough in engineering systems of ... to important improvements across a range of industries, ... will use these new "RNA machines", to adjust ...
... - Drugs used to overcome cancer may also combat ... Wright, scientific director of the Michael G. DeGroote Institute ... study found that certain proteins, called kinases, that confer ... cancer," says Wright about the study published in Chemistry ...
... Albert Einstein College of Medicine of Yeshiva ... control the survival of messenger RNA ( mRNA ) arguably ... help regulate cell division and could therefore have implications for ... today,s online edition of the journal Cell . , ...
Cached Biology News:DOE researchers achieve important genetic breakthroughs to help develop cheaper biofuels 2Built-in 'self-destruct timer' causes ultimate death of messenger RNA in cells 2Built-in 'self-destruct timer' causes ultimate death of messenger RNA in cells 3
A univariate (peak height or area) quantitative multi-component analysis package....
... Antigen sequence: H-Ala-Cys-Asp-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH 2 ... our corresponding peptide and ... 5 I-labelled peptide, ... (H-1470) and ([ 1 ...
... is a dramatic breakthrough in accurate, small-volume bulk ... resolution, the micro 1 has unique advantages not ... micro 1 never needs re-calibration as do other ... on an LCD Display , Graphical Row Selection ...
... expression profiling allows a high-throuput screening of ... occuring or artifitially induced changes in the ... system can be detected, studied, classified and ... range of genes at a glance. Automatized ...
Biology Products: